Trial Radar IA

Discutiamo ed esploriamo gli studi clinici con Chugai Pharmaceutical come promotore principale o collaboratore.

Posso aiutarti a capire le condizioni di salute, i trattamenti o a trovare studi clinici vicini.
Il nostro strumento di ricerca supporta solo l'inglese. Per la ricerca e la discussione in altre lingue, usa Trial Radar IA sopra o seleziona i filtri per condizione medica e luogo (qui sotto).
14 studi clinici
 
Fascia d'età
Adulto Anziano
×
 
Intervento
PLACEBO
×
 
Titolo dello studio
Stato
Study of DONQ52 in Active Celiac Disease NCT07239336
In arruolamento
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-2) NCT06819891
In arruolamento
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1) NCT06819878
In arruolamento
A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (Ametrine-1) NCT06589986
Attivo, non in arruolamento
A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152) (SKYSCRAPER-14) NCT05904886
Attivo, non in arruolamento
Uno studio per valutare l'efficacia, la sicurezza, la farmacocinetica (PK) e la farmacodinamica (PD) di satralizumab nei partecipanti con encefalite anti-recettore N-metil-D-aspartico (NMDAR) o anti-leucine-rich glioma-inactivated 1 (LGI1) (Cielo) NCT05503264
In arruolamento
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barré Syndrome (GBS) NCT05494619
Ritirato
Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients NCT05425446
Completato
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (Meteoroid) NCT05271409
In arruolamento
A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis NCT04963270
TerminatoRisultati pubblicati
A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism NCT04209179
Terminato
A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer (IMpassion050) NCT03726879
CompletatoRisultati pubblicati
Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria (COMPOSER) NCT03157635
Attivo, non in arruolamento
A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis NCT02965053
Completato